Absence of favourable changes in circulating levels of interleukin-16 or β-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection

  1. Montes de Oca Arjona, M.
  2. Pérez Cano, R.
  3. Orozco, M.J.
  4. Martín Aspas, A.
  5. Guerrero, F.
  6. Fernández Gutiérrez del Álamo, C.
  7. Girón-González, J.A.
Revue:
Clinical Microbiology and Infection

ISSN: 1198-743X

Année de publication: 2005

Volumen: 11

Número: 1

Pages: 57-62

Type: Article

DOI: 10.1111/J.1469-0691.2004.01033.X GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable